Diabetes Devices Market Trends

  • Report ID: 4642
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Diabetes Devices Market Growth Drivers and Challenges:

Growth Drivers

  • Technological Advancements in Diabetes Monitoring Devices – The advancements in science, technology, and manufacturing will help to manage the treatment of type 1 diabetes. People suffering from diabetes do not produce enough insulin or cannot use the insulin produced in the required way. The unavailability of insulin increases sugar levels in the blood. So, it is necessary to regulate the blood glucose levels in these people through regular monitoring. Many advancements have been made to make this process user-friendly, which is estimated to drive the diabetes devices market growth in the coming years. In 2020, the U.S Food and Drug Administration (FDA) approved a hybrid closed-loop management device named ‘Minimed770G’. This will keep an eye on the sugar levels and helps caregivers of users to estimate the appropriate insulin doses.

  • Rising Gestational Diabetes Cases – As per the Centers for Disease Control and Prevention (CDC), gestational diabetes increased by 29% from 2016 to 2020 in the United States.
  • Sedentary Lifestyle and Lack of Physical Activity – As per the CDC, over 60% of adults in the U.S do not participate in the recommended physical activity, and 25% of them are completely inactive.
  • Increasing Geriatric Population Across the Globe – The older population aged 65 and above across the U.S. was 54.1 million in 2019, as per the Administration for Community Living.
  • Rising Personal Disposable Income – The disposable personal income of the U.S population as per the Bureau of Economic Analysis 2022, increased to USD 67.6 billion and the personal consumption expenditure rose to USD 67.5 billion.

Challenges

  • Lack of Exact Blood Glucose Measurement – Although monitoring glucose has become a crucial element of treating diabetes, its precision has certain drawbacks. For the variations in strip production, strip storage, and strip ageing, accuracy may be restricted. They might also be the result of patient issues such as inaccurate coding, insufficient hand washing, a changed hematocrit, or naturally existing interfering chemicals, or environmental restrictions such as temperature or altitude.
  • The Presence of Adverse Effects
  • Lack of Knowledge to Operate Devices

Base Year

2025

Forecast Period

2026-2035

CAGR

8.5%

Base Year Market Size (2025)

USD 34.18 billion

Forecast Year Market Size (2035)

USD 77.28 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of diabetes devices is estimated at USD 36.79 billion.

The global diabetes devices market size crossed USD 34.18 billion in 2025 and is likely to register a CAGR of over 8.5%, exceeding USD 77.28 billion revenue by 2035.

North America diabetes devices market is predicted to capture 39.8% share by 2035, driven by increased prevalence of diabetes, rising healthcare expenditure, and strong healthcare network.

Key players in the market include Medtronic plc, Abbott Laboratories, ARKRAY, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos